180 related articles for article (PubMed ID: 37017857)
1. Continuous subcutaneous rhPTH infusion for managing difficult chronic hypoparathyroidism. A systematic review.
Gamarra E; Retta F; Lucatello B; Ragazzoni F; Camponovo C; Deandrea M; Trimboli P
Endocrine; 2023 Aug; 81(2):194-205. PubMed ID: 37017857
[TBL] [Abstract][Full Text] [Related]
2. Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.
Aouchiche K; Reynaud R; Amodru V; Brue T; Cuny T
Endocrine; 2022 Apr; 76(1):179-188. PubMed ID: 34984624
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.
Linglart A; Rothenbuhler A; Gueorgieva I; Lucchini P; Silve C; Bougnères P
J Clin Endocrinol Metab; 2011 Nov; 96(11):3308-12. PubMed ID: 21865375
[TBL] [Abstract][Full Text] [Related]
7. Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.
Winer KK; Zhang B; Shrader JA; Peterson D; Smith M; Albert PS; Cutler GB
J Clin Endocrinol Metab; 2012 Feb; 97(2):391-9. PubMed ID: 22090268
[TBL] [Abstract][Full Text] [Related]
8. Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report.
Saraiva M; Chaves AC; Assunção G; Saraiva J; Carvalho R
Am J Case Rep; 2021 Aug; 22():e931739. PubMed ID: 34389697
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone therapy for hypoparathyroidism.
Cusano NE; Rubin MR; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
[TBL] [Abstract][Full Text] [Related]
10. Continuous Subcutaneous Delivery of rhPTH(1-84) and rhPTH(1-34) by Pump in Adults With Hypoparathyroidism.
Charoenngam N; Bove-Fenderson E; Wong D; Cusano NE; Mannstadt M
J Endocr Soc; 2024 Mar; 8(5):bvae053. PubMed ID: 38562130
[TBL] [Abstract][Full Text] [Related]
11. Management of Hypoparathyroidism: Present and Future.
Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.
Kim ES; Keating GM
Drugs; 2015 Jul; 75(11):1293-303. PubMed ID: 26177893
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP
Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413
[TBL] [Abstract][Full Text] [Related]
14. Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism.
Fuss CT; Burger-Stritt S; Horn S; Koschker AC; Frey K; Meyer A; Hahner S
Endocrinol Diabetes Metab Case Rep; 2020 May; 2020():. PubMed ID: 32478671
[TBL] [Abstract][Full Text] [Related]
15. Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism.
Edafe O; Mech CE; Balasubramanian SP
Cochrane Database Syst Rev; 2019 May; 5(5):CD012845. PubMed ID: 31116878
[TBL] [Abstract][Full Text] [Related]
16. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
Marcucci G; Della Pepa G; Brandi ML
Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
[TBL] [Abstract][Full Text] [Related]
17. The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics.
Gittoes N; Rejnmark L; Ing SW; Brandi ML; Björnsdottir S; Hahner S; Hofbauer LC; Houillier P; Khan AA; Levine MA; Mannstadt M; Shoback DM; Vokes TJ; Zhang P; Marelli C; Germak J; Clarke BL
BMC Endocr Disord; 2021 Nov; 21(1):232. PubMed ID: 34801015
[TBL] [Abstract][Full Text] [Related]
18. Improving management of severe hypoparathyroidism: a case series.
Ugalde-Abiega B; Lamas Oliveira C; Alfaro Martínez JJ; Meizoso-Pita O; Sevillano Collantes C; Gomez García I; Perez Rodríguez A; Huguet I
Hormones (Athens); 2022 Mar; 21(1):71-77. PubMed ID: 34647284
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM.
Lakatos P; Bajnok L; Lagast H; Valkusz Z
Endocr Pract; 2016 May; 22(5):523-32. PubMed ID: 26684150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
